不断扩展的肠促胰素领域:从基础生物学到临床转化
肠促胰素激素主要包括葡萄糖依赖性促胰岛素多肽(GIP)和胰高血糖素样肽-1(GLP-1),通过直接和间接途径增强进餐刺激的胰岛素分泌,并调节胰高血糖素分泌。GIPR和GLP-1R广泛分布于胰腺外的脑、心血管、免疫系统、肠道和肾脏,支持了肠促胰素疗法在2型糖尿病和肥胖治疗中的开发。本文综述肠促胰素作用概念的演变,主要聚焦GLP-1,从发现到临床概念验证再到治疗结局,区分已确立与不确定的作用机制。
要点
- GIP和GLP-1通过直接(GIP+GLP-1)和间接(GLP-1)作用于胰岛β细胞增强进餐刺激的胰岛素分泌。
- GIPR和GLP-1R广泛分布于胰腺外组织,支持肠促胰素的多重胰外作用。
- 肠促胰素的血糖调节和厌食活性支持了其疗法在2型糖尿病和肥胖中的开发。
核心结论
- 肠促胰素激素GIP和GLP-1通过直接和间接途径增强进餐刺激的胰岛素分泌并调节胰高血糖素分泌,其受体广泛分布于胰腺外组织,支持了肠促胰素疗法在2型糖尿病和肥胖治疗中的开发。
研究设计与样本
- 本文为综述,聚焦于GLP-1,从发现、临床概念验证到治疗结局,综述肠促胰素作用概念的演变。
主要发现
- GIP和GLP-1通过直接(GIP+GLP-1)和间接(GLP-1)作用于胰岛β细胞增强进餐刺激的胰岛素分泌。
- GIP和GLP-1通过直接和间接途径调节胰高血糖素分泌。
- GIPR和GLP-1R广泛分布于胰腺外的脑、心血管和免疫系统、肠道和肾脏,与广泛的胰外肠促胰素作用一致。
- GIP和GLP-1的血糖调节和厌食活性支持了肠促胰素疗法在2型糖尿病和肥胖治疗中的开发。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文指出需要额外澄清的活跃研究领域和不确定性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Incretin hormones, principally glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1(GLP-1), potentiate meal-stimulated insulin secretion through direct (GIP + GLP-1) and indirect (GLP-1) actions on islet β-cells. GIP and GLP-1 also regulate glucagon secretion, through direct and indirect pathways. The incretin hormone receptors (GIPR and GLP-1R) are widely distributed beyond the pancreas, principally in the brain, cardiovascular and immune systems, gut and kidney, consistent with a broad array of extrapancreatic incretin actions. Notably, the glucoregulatory and anorectic activities of GIP and GLP-1 have supported development of incretin-based therapies for the treatment of type 2 diabetes and obesity. Here we review evolving concepts of incretin action, focusing predominantly on GLP-1, from discovery, to clinical proof of concept, to therapeutic outcomes. We identify established vs uncertain mechanisms of action, highlighting biology conserved across species, while illuminating areas of active investigation and uncertainty that require additional clarification.
引用
- Drucker DJ, Holst JJ. The expanding incretin universe: from basic biology to clinical translation. Diabetologia. 2023. PMID: 36976349. doi:10.1007/s00125-023-05906-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。